Seiya Miyamoto
Kawasaki, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Retraction: 'Effect of blonanserin on cognitive function in antipsychotic-naïve first-episode schizophrenia'.
Journal: Human psychopharmacology
Published: June 29, 2017
The Use of Long-Acting Injectable Antipsychotics in Schizophrenia.
Journal: Current treatment options in psychiatry
Published: June 06, 2017
Effectiveness of N-acetylcysteine in the treatment of schizophrenia
Journal: Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology
Published: June 24, 2016
Effects of N-Acetylcysteine on Cognitive Functions in Subjects With an At-Risk Mental State: A Case Series.
Journal: Journal of clinical psychopharmacology
Published: December 15, 2015
New therapeutic approaches for treatment-resistant schizophrenia: a look to the future.
Journal: Journal of psychiatric research
Published: April 14, 2014
Long-term efficacy and safety of blonanserin in patients with first-episode schizophrenia: a 1-year open-label trial.
Journal: Psychiatry and clinical neurosciences
Published: December 25, 2013
Profile of blonanserin for the treatment of schizophrenia.
Journal: Neuropsychiatric disease and treatment
Published: June 15, 2013
Blonanserin in the treatment of schizophrenia
Journal: Nihon rinsho. Japanese journal of clinical medicine
Published: May 18, 2013
Benefits and limits of anticholinergic use in schizophrenia: focusing on its effect on cognitive function.
Journal: Psychiatry and clinical neurosciences
Published: February 26, 2013
Alternative pharmacologic targets for the treatment of schizophrenia: results from phase I and II trials.
Journal: Current opinion in psychiatry
Published: January 05, 2013
New serotonin/dopamine antagonists for the treatment of schizophrenia: are we making real progress?
Journal: Clinical schizophrenia & related psychoses
Published: September 26, 2012
Last Updated: 09/26/2026